Advanced Insights into Residual Cardiovascular Risk
Description: Dr. Cesar Molina discusses residual risk and the need to reclassify patients with existing cardiovascular disease; discuss why cardiovascular disease exists despite managing patients to lipid goals and discuss the unique solution of the core offering from Quest Diagnostics Cardio IQ.
At the conclusion of this program, participants will be able to:
--Understand why Advanced Cardiovascular testing is beneficial
--Review two key cardiovascular risk factors: Lp(A) and ApoB
--Identify the biomarkers for assessment of inflammation
--Discuss the clinical importance of LDL sub-fractions
--Introduce the Cardio IQ Report as a management solution beyond the routine Lipid Panel